S&P 500 Hits New High on Delayed and Reduced Rate Hike Expectations
The S&P 500 (Index: SPX) reached a new record high close of 7,798.99 on Thursday, 13 August 2026 before falling back on Friday to end the trading week at 7,785.76.
Two developments helped to spur the index to its new heights. First, investors received good inflation news on Wednesday, 12 August 2026 when the Consumer Price Index came in lower than expected. The second came on Thursday, when the Producer Price Index was likewise reported to be lower than expected.
Because of these benign consumer and producer price inflation reports, the CME Group’s FedWatch Tool no longer anticipates the Fed will act to hike the Federal Funds Rate from its current target range of 3.50-3.75% in September 2026, but will instead delay a quarter point rate hike to take place sometime in the fourth quarter of 2026. In its latest snapshot, the FedWatch Tool sees a falling 53% chance the Fed will act to hike this core interest rate to a target range of 3.75-4.00% on 28 October (2026-Q4) but gives a more solid 93% chance this rate will be in effect on 9 December (2026-Q4).
With the next rate hike likely delayed and fewer rate hikes on the table as a result of the better than expected inflation reports, the resulting lower interest rates kept investors focused on the first quarter of 2027 as they set current day stock prices. The latest update of the alternative futures chart shows the level of stock prices is right where they dividend futures-based model forecasts it would be provided investors are focused on 2027-Q1.
While those were the biggest headlines, other things happened that contributed to the random onset of new information investors absorbed and reacted to during the week that was. Here is our summary of the week’s market moving headlines:
- Monday, 10 August 2026
-
- Signs and portents for the U.S. economy:
- July US container imports hit fourth-highest on record, Descartes says
- Oil climbs 5% as Iran, US both demand compensation and Hormuz hopes fade
- Lower inflation, global ambitions developing in China:
- China July factory-gate inflation eases to 3-month low, CPI slows
- China’s central bank vows to expand yuan’s international use in five-year plan
- China bypasses shipping chokepoints with ‘Ice Silk Road’ through Arctic
- Bigger trouble developing in Japan as BOJ minions plan next rate hikes:
- BOJ’s rate-hike path runs into Takaichi’s bond market problems
- BOJ’s debate on faster hikes bolsters September rate move odds
- Bigger trouble developing in Eurozone:
- Wall Street concluded moderately lower as hopes for Hormuz reopening fade
- Tuesday, 11 August 2026
-
- Signs and portents for the U.S. economy:
- US court rules Meta, other tech firms must face thousands of lawsuits over social media addiction
- US existing home sales fall further; small business sentiment at 11-month high
- Oil prices settle up as Iran says Strait of Hormuz to stay shut
- US auto loans hit record high in second quarter, New York Fed says
- US officials work to close supply chain gaps as foreign investment grows
- Fed minions say inflation is their biggest problem:
- Inflation is the biggest problem, Fed’s Goolsbee says
- Atlanta Fed’s Venable: Inflation too high, with prospect of easing dependent on events in Middle East
- Bigger trouble, stimulus developing in China:
- China’s car sales extend slide as shift accelerates to overseas markets
- Surge in China’s coal imports may start to taper off
- Bigger trouble developing in Japan:
- Wall Street ended lower as eyes remain on the Middle East and upcoming inflation data
- Wednesday, 12 August 2026
-
- Signs and portents for the U.S. economy:
- Headline CPI rises 3.4% in July, slowing from June’s pace
- Rate-Hike Odds Tumble As US Consumer Price Inflation Prints Slowest Since Pre-War
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- Mortgage rates finally stop rising, causing demand to trickle back
- Before the CPI inflation report: Fed minions say poor Americans are struggling to make ends meet, want to hike their interest rates:
- Investors worry leaner Fed guidance may come at a price
- After the CPI inflation report:
- Bigger trouble, stimulus developing in China:
- Wall Street finished up in the green after the latest inflation report
- 23 dividend safety stocks beating the S&P 500 this year
- Thursday, 13 August 2026
-
- Signs and portents for the U.S. economy:
- US producer prices unchanged in July, further dimming rate hike odds
- Oil settles down 2% on weak demand outlook, hefty US crude build
- One Fed minion notices inflation data doesn’t support rate hikes, other Fed minion is slow on the uptake, while third is flapping in the wind:
- Fed’s Goolsbee says latest inflation data is better
- Fed should raise rates to restrain growth and inflation, Hammack says
- Fed’s Barkin: Still an “open question” if rate hike will be needed to meet inflation target
- BOJ minions excited to get inflation data to support their plans to keep hiking Japan’s interest rates:
- Japan’s wholesale inflation stays hot, bolstering odds of September BOJ hike
- Rate hike bets leave yen’s post-intervention gains at BOJ’s mercy
- Wall Street ended on top as the S&P 500 notched a new record high
- Friday, 14 August 2026
-
- Signs and portents for the U.S. economy:
- US retail sales post first decline in nine months in July
- Oil set for weekly gains after US threatens indefinite blockade of Iran
- Fed rate hike odds sink further as retail sales, consumer sentiment fall
- Fed minions expected to sit on hands rather than hike rates in September 2026:
- Bigger trouble developing in and out of China:
- China July bank loans post record contraction as credit demand falters
- Chinese car sales are booming almost everywhere – just not at home
- BOJ minions getting super excited to hike Japan’s interest rates again:
- Central bank minions around globe betting big on gold:
- Wall Street ended lower a day after the S&P 500 notched a record high
The Atlanta Fed’s GDPNow tool anticipates real GDP growth for the U.S. economy of +4.3% in 2026-Q3, down from the +5.8% annualized growth it forecast a week earlier.
Image credit: Microsoft Copilot Designer. Prompt: “An editorial cartoon of a Wall Street bull and bear who give each other a high-five after news breaks that inflation came in lower than expected while Federal Reserve officials are sad they won’t be able to hike U.S. interest rates when they wanted”.
Source: https://politicalcalculations.blogspot.com/2026/08/s-500-hits-new-high-on-delayed-and.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.



